Literature DB >> 31609183

Plasma cell leukemia with plasmablastic morphology in a dog.

Elie Dagher1,2,3, Nicolas Soetart1,2,3, Florian Chocteau1,2,3, Bérengère Dequéant1,2,3, Esther Piccirillo1,2,3, Catherine Ibisch1,2,3, Jérôme Abadie1,2,3, Laëtitia Jaillardon1,2,3.   

Abstract

A 5-y-old female Golden Retriever was presented with a 2-wk history of hyporexia, vomiting, diarrhea, lethargy, weight loss, polyuria, and polydipsia. Clinical examination and ultrasonography revealed multiple organ enlargement with gallbladder and kidney nodules suggestive of disseminated neoplasia. Hematologic and biochemical analyses revealed pancytopenia, hypercalcemia, and monoclonal IgA gammopathy suspicious for a plasma cell neoplasm. Bone marrow and blood smear examination revealed neoplastic atypical cells highly suggestive of lymphoid origin. Autopsy confirmed the presence of homogeneous white masses and multifocal pale infiltrates in the spleen, kidney, small intestine, gallbladder, and urinary tract. Histologic features were consistent with a multicentric atypical plasma cell tumor. Tumor cells were negative for CD204, IBA-1, E-cadherin, CD3, CD5, CD79a, CD20, and PAX5, and positive for MUM1, consistent with plasma cell origin. The presence of > 20% of circulating blastic plasma cells was consistent with primary plasma cell leukemia with plasmablastic morphology, a disease rarely described in veterinary medicine.

Entities:  

Keywords:  canine; hematopoietic neoplasia; plasma cell leukemia

Mesh:

Year:  2019        PMID: 31609183      PMCID: PMC6900715          DOI: 10.1177/1040638719882045

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  23 in total

1.  AIDS-related plasmablastic lymphomas of the oral cavity and jaws: a diagnostic dilemma.

Authors:  A Carbone; G Gaidano; A Gloghini; A Ferlito; A Rinaldo; H Stein
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-01       Impact factor: 1.547

2.  Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.

Authors:  A Carbone; A Gloghini; L M Larocca; D Capello; F Pierconti; V Canzonieri; U Tirelli; R Dalla-Favera; G Gaidano
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

Review 3.  A review of histiocytic diseases of dogs and cats.

Authors:  P F Moore
Journal:  Vet Pathol       Date:  2014-01       Impact factor: 2.221

4.  A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1.

Authors:  J Wijdenes; W C Vooijs; C Clément; J Post; F Morard; N Vita; P Laurent; R X Sun; B Klein; J M Dore
Journal:  Br J Haematol       Date:  1996-08       Impact factor: 6.998

5.  Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.

Authors:  Francisco Vega; Chung-Che Chang; Leonard J Medeiros; Mark M Udden; Jeong Hee Cho-Vega; Ching-Ching Lau; Chris J Finch; Regis A Vilchez; David McGregor; Jeffrey L Jorgensen
Journal:  Mod Pathol       Date:  2005-06       Impact factor: 7.842

Review 6.  Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.

Authors:  C Fernández de Larrea; R A Kyle; B G M Durie; H Ludwig; S Usmani; D H Vesole; R Hajek; J F San Miguel; O Sezer; P Sonneveld; S K Kumar; A Mahindra; R Comenzo; A Palumbo; A Mazumber; K C Anderson; P G Richardson; A Z Badros; J Caers; M Cavo; X LeLeu; M A Dimopoulos; C S Chim; R Schots; A Noeul; D Fantl; U-H Mellqvist; O Landgren; A Chanan-Khan; P Moreau; R Fonseca; G Merlini; J J Lahuerta; J Bladé; R Z Orlowski; J J Shah
Journal:  Leukemia       Date:  2012-11-21       Impact factor: 11.528

7.  The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.

Authors:  Emina Torlakovic; Goran Torlakovic; Phuong L Nguyen; Richard D Brunning; Jan Delabie
Journal:  Am J Surg Pathol       Date:  2002-10       Impact factor: 6.394

Review 8.  Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance.

Authors:  L de Leval; N L Harris
Journal:  Histopathology       Date:  2003-12       Impact factor: 5.087

9.  Multiple myeloma: significance of plasmablastic subtype in morphological classification.

Authors:  P R Greipp; N M Raymond; R A Kyle; W M O'Fallon
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

10.  Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies.

Authors:  Elspeth M Waugh; Alice Gallagher; Hayley Haining; Pamela E J Johnston; Francesco Marchesi; Ruth F Jarrett; Joanna S Morris
Journal:  Vet Immunol Immunopathol       Date:  2016-10-19       Impact factor: 2.046

View more
  1 in total

Review 1.  Bite-size introduction to canine hematologic malignancies.

Authors:  Matthew J Atherton; Nicola J Mason
Journal:  Blood Adv       Date:  2022-07-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.